Open Access · CC BY 4.0
Chronic and emerging immune-related adverse events from immune checkpoint inhibitors
Disease and Therapeutics · 2026 · 2 · 100011
DOI: 10.1016/j.dist.2026.100011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Connor Frey. Die Arbeit nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Frey, C. (2026). Chronic and emerging immune-related adverse events from immune checkpoint inhibitors. Disease and Therapeutics, 2, 100011. https://doi.org/10.1016/j.dist.2026.100011
Vancouver
Frey C. Chronic and emerging immune-related adverse events from immune checkpoint inhibitors. Disease and Therapeutics. 2026;2:100011. doi:10.1016/j.dist.2026.100011
BibTeX
@article{Frey2026,
author = {Frey, Connor},
title = {Chronic and emerging immune-related adverse events from immune checkpoint inhibitors},
journal = {Disease and Therapeutics},
year = {2026},
volume = {2},
pages = {100011},
doi = {10.1016/j.dist.2026.100011}
}
EUVIMED